Cerebral Palsy is the most common motor disability in childhood. Population-based studies from around the world report prevalence estimates range from 1.5 to more than 4 per 1,000 live births. Convaid and R82 products are often prescribed for children living with Cerebral Palsy. Today, the pediatric group announced the launch of a three-part Cerebral Palsy webinar series, the first of which to be held on Thursday, September 22, 2016, to be presented by seating and mobility expert K. Missy Ball.
Missy is MT, PT, ATP, a certified pediatric NDT, who is the former Acting Director of the Physical Therapy Department of Children’s Hospital in New Orleans, where she co-directed the hospital’s seating program for 10-years. She has worked with United Cerebral Palsy Center’s Seating Clinic.
All webinars will start at 9:30AM PDT/11:30am CDT/12:30PM EDT at no charge to attendees.
This webinar will focus on defining cerebral palsy, causes, risks factors, classification and description of the different types, as well as specific seating & mobility issues. Classification is based on type, bodily involvement and severity. The Gross Motor Functional Classification Scale will be discussed as a reference for Cerebral Palsy severity and equipment options. Specific clinical manifestations found in each type of cerebral palsy will be explored and seating and mobility options to address these presented. Convaid and R82 products will be emphasized.
Course 2 | Cerebral Palsy: Standing and Walking | Thursday, October 20, 2016
Course 3 | Cerebral Palsy: Use of Home Equipment | Thursday, November 17, 2016.
Click here to register for the no fee webinar.
Throughout North America, Convaid and R82 market products in the following categories:
The Convaid and R82 brands offer pediatric products typically prescribed to individuals with mild to moderate involvement of the following conditions: Cerebral Palsy, Down Syndrome, Duchene Muscular Dystrophy, Spinal Muscular Atrophy, Spina Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders, among others.